RAPPORT THERAPEUTICS INC. - COMMON STOCK

12.68

21-February-25 16:45:00

15 minutes delayed

Stocks

-0.32

-2.46%

Today's range

12.50 - 13.25

ISIN

N/A

Source

NASDAQ

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

09 Jan 2025 09:12:59 By Nasdaq GlobeNewswire
Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

09 Jan 2025 07:00:00 By Nasdaq GlobeNewswire
Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

06 Dec 2024 12:01:00 By Nasdaq GlobeNewswire
Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting

14 Nov 2024 07:00:02 By Nasdaq GlobeNewswire
Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update

07 Nov 2024 07:00:01 By Nasdaq GlobeNewswire
Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November

04 Nov 2024 07:00:00 By Nasdaq GlobeNewswire
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences

05 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

<<
<
1
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.